The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predicting sensitivity to azacytidine in non-small cell cancer lines by absence of activating mutations.
John Wrangle
No relevant relationships to disclose
Helai P Mohammad
No relevant relationships to disclose
Abde Abukhdeir
No relevant relationships to disclose
Rosalyn A. Juergens
No relevant relationships to disclose
Kirsten Harbom
No relevant relationships to disclose
Kristen Rodgers
No relevant relationships to disclose
James Shin
No relevant relationships to disclose
Cynthia A. Zahnow
No relevant relationships to disclose
Stephen Baylin
No relevant relationships to disclose
James Gordon Herman
No relevant relationships to disclose
Charles M. Rudin
No relevant relationships to disclose
Malcolm Brock
No relevant relationships to disclose